[{"Assets_0_Q2_USD":122193000.0,"CommonStockSharesOutstanding_0_Q2_shares":42684000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-5036000.0,"NetIncomeLoss_1_Q2_USD":-4651000.0,"NetIncomeLoss_2_Q2_USD":-12310000.0,"StockholdersEquity_0_Q2_USD":90598000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":19011000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":37038000.0,"Ticker":"VCEL","CIK":"887359","name":"VERICEL CORP","OfficialName":"Vericel Corporation Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1756775066.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180806"}]